Today: 9 June 2026
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus
7 February 2026
1 min read

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

New York, Feb 7, 2026, 17:16 EST — The market has closed.

Linde plc dropped 2.5% to close at $448.24 on Friday. The stock saw action between $445.00 and $461.65, with roughly 3.1 million shares traded.

Linde sits at the top of the industrial gases sector—its products power everything from chemical plants to steel mills, food processors, and more. Investors often turn to Linde’s numbers for clues on the broader state of industrial production. Moves here tend to echo across competitors like Air Products and Air Liquide.

During the earnings call, CEO Sanjiv Lamba pointed to “unprecedented activity” in 2025, fueled by AI and digital infrastructure investment. “Traditional industrial markets,” he noted, saw “continued retrenchment.” After shares slipped, CFO Matt White said Linde lifted fourth-quarter buybacks to $1.4 billion. As for pricing, Lamba expects it to align over time with a globally weighted consumer inflation rate.

Linde’s fourth-quarter numbers: sales up 6% to $8.764 billion, with adjusted EPS landing at $4.20. For 2026, the company is projecting full-year adjusted EPS in the $17.40 to $17.90 range, and it’s planning to spend $5.0 to $5.5 billion on capital projects—backed by a $10.0 billion pipeline. In 2025, Linde returned $7.4 billion to its shareholders. CEO Lamba said the firm is set to deliver value “regardless of macroeconomic uncertainties.” Linde Assets

Linde attached its earnings press release as an exhibit to a Form 8-K, according to a U.S. regulatory filing dated Feb. 5.

JPMorgan has cut its rating on Linde to Neutral from Overweight, keeping the $455 price target steady. The call comes down to valuation, plus two quarters where sequential pricing didn’t budge, with helium prices partly to blame. According to the bank, Linde’s valuation multiple may remain stuck until pricing momentum picks up.

Morgan Stanley bumped its price target on Linde up to $530, previously $495, sticking with an Overweight rating. Despite a tough operating environment, analysts flagged productivity moves, new projects coming online, and some FX tailwinds as key positives.

UBS upped its price target to $550 from $500 and kept its Buy rating in place, noting the company’s results looked “slightly less conservative” than what analysts had been bracing for. TipRanks

The immediate worry centers on Linde’s 2026 outlook—does it provide enough cushion if industrial demand remains sluggish and pricing fails to pick back up? According to an Investing.com piece, the company’s midpoint for full-year adjusted EPS guidance actually landed under where analysts had pegged it, despite the latest quarter topping estimates.

U.S. markets reopen Monday, Feb. 9. On the calendar: management is due at Citi’s 2026 Global Industrial Tech and Mobility Conference on Feb. 17, followed by the 43rd Annual Industrial Select Conference from Barclays on Feb. 18.

Stock Market Today

  • Broadcom Stock Set for 27% Gain to $500 Amid AI Growth, Despite Recent Selloff
    June 9, 2026, 10:08 AM EDT. Broadcom (NASDAQ:AVGO) shares dropped nearly 14% post-earnings despite 47.87% revenue growth and an eighth straight earnings per share (EPS) beat. The stock trades around $396.60, with a 24/7 Wall St. price target of $503.61, implying a 26.98% upside over 12 months and a buy recommendation at 90% confidence. Broadcom's Q2 revenue hit $22.19 billion with a 143% jump in AI semiconductor sales to $10.8 billion. CEO Hock Tan projects over 200% AI revenue growth in Q3, targeting $16 billion. Bear risks include heavy insider selling and a high 64 forward P/E ratio. Bulls note strong AI demand, with price targets up to $600 billion revenue potential by 2028. The stock remains 14.82% higher year-to-date despite recent volatility.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Shell stock: What to watch after PwC audit switch and Kazakhstan warning as buybacks roll on
Previous Story

Shell stock: What to watch after PwC audit switch and Kazakhstan warning as buybacks roll on

Deutsche Telekom stock slips despite fresh buyback — what matters before earnings
Next Story

Deutsche Telekom stock slips despite fresh buyback — what matters before earnings

Go toTop